Challenges in Synthetic Biology Investment

This chapter examines Facebook's struggles with talent retention and public image, likening its situation to that of a tobacco company. It also investigates Ginkgo Bioworks and its controversial business model amidst allegations of financial misrepresentation and a significant stock drop following a critical report. The discussion emphasizes the intricacies of startup valuations and the ethical dilemmas surrounding transparency in the tech industry.